Detalles de la búsqueda
1.
Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.
PLoS One;
16(4): e0249807, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33819274
2.
Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.
PLoS One;
15(8): e0237030, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810141
3.
In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations.
Leuk Res;
30(11): 1443-6, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16546254
4.
Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer.
Clin Cancer Res;
10(22): 7721-6, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15570006
5.
NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients.
Leuk Res;
38(5): 619-24, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679585
6.
NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways.
Blood Cancer J;
8(7): 62, 2018 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941953
7.
Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.
Anticancer Res;
32(3): 795-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22399596
8.
Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives.
Bioorg Med Chem Lett;
17(10): 2712-7, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17376680
9.
Isolation, cloning, and characterization of a novel phosphomannan-binding lectin from porcine serum.
J Biol Chem;
282(17): 12963-75, 2007 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-17324926
10.
Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.
Bioorg Med Chem Lett;
16(5): 1421-5, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16332440
11.
NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia.
Blood;
106(12): 3948-54, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16105974
Resultados
1 -
11
de 11
1
Próxima >
>>